Literature DB >> 29467316

Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus.

Jonathan C Reed1, Nick Westergreen2, Brook C Barajas3, Dylan T B Ressler2, Daryl J Phuong3, John V Swain2, Vishwanath R Lingappa2, Jaisri R Lingappa3.   

Abstract

During immature capsid assembly in cells, human immunodeficiency virus type 1 (HIV-1) Gag co-opts a host RNA granule, forming a pathway of intracellular assembly intermediates containing host components, including two cellular facilitators of assembly, ABCE1 and DDX6. A similar assembly pathway has been observed for other primate lentiviruses. Here we asked whether feline immunodeficiency virus (FIV), a nonprimate lentivirus, also forms RNA granule-derived capsid assembly intermediates. First, we showed that the released FIV immature capsid and a large FIV Gag-containing intracellular complex are unstable during analysis, unlike for HIV-1. We identified harvest conditions, including in situ cross-linking, that overcame this problem, revealing a series of FIV Gag-containing complexes corresponding in size to HIV-1 assembly intermediates. Previously, we showed that assembly-defective HIV-1 Gag mutants are arrested at specific assembly intermediates; here we identified four assembly-defective FIV Gag mutants, including three not previously studied, and demonstrated that they appear to be arrested at the same intermediate as the cognate HIV-1 mutants. Further evidence that these FIV Gag-containing complexes correspond to assembly intermediates came from coimmunoprecipitations demonstrating that endogenous ABCE1 and the RNA granule protein DDX6 are associated with FIV Gag, as shown previously for HIV-1 Gag, but are not associated with a ribosomal protein, at steady state. Additionally, we showed that FIV Gag associates with another RNA granule protein, DCP2. Finally, we validated the FIV Gag-ABCE1 and FIV Gag-DCP2 interactions with proximity ligation assays demonstrating colocalization in situ Together, these data support a model in which primate and nonprimate lentiviruses form intracellular capsid assembly intermediates derived from nontranslating host RNA granules.IMPORTANCE Like HIV-1 Gag, FIV Gag assembles into immature capsids; however, it is not known whether FIV Gag progresses through a pathway of immature capsid assembly intermediates derived from host RNA granules, as shown for HIV-1 Gag. Here we showed that FIV Gag forms complexes that resemble HIV-1 capsid assembly intermediates in size and in their association with ABCE1 and DDX6, two host facilitators of HIV-1 immature capsid assembly that are found in HIV-1 assembly intermediates. Our studies also showed that known and novel assembly-defective FIV Gag mutants fail to progress past putative intermediates in a pattern resembling that observed for HIV-1 Gag mutants. Finally, we used imaging to demonstrate colocalization of FIV Gag with ABCE1 and with the RNA granule protein DCP2. Thus, we conclude that formation of assembly intermediates derived from host RNA granules is likely conserved between primate and nonprimate lentiviruses and could provide targets for future antiviral strategies.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  ABCE1; DCP2; DDX6; FIV; Gag; HIV; immature capsid assembly

Mesh:

Substances:

Year:  2018        PMID: 29467316      PMCID: PMC5899207          DOI: 10.1128/JVI.01761-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  94 in total

1.  FATCAT: a web server for flexible structure comparison and structure similarity searching.

Authors:  Yuzhen Ye; Adam Godzik
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

Review 2.  P-bodies and stress granules: possible roles in the control of translation and mRNA degradation.

Authors:  Carolyn J Decker; Roy Parker
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

3.  Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface.

Authors:  David C Goldstone; Melvyn W Yap; Laura E Robertson; Lesley F Haire; William R Taylor; Aris Katzourakis; Jonathan P Stoye; Ian A Taylor
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

Review 4.  P bodies: at the crossroads of post-transcriptional pathways.

Authors:  Ana Eulalio; Isabelle Behm-Ansmant; Elisa Izaurralde
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

5.  P-body formation is a consequence, not the cause, of RNA-mediated gene silencing.

Authors:  Ana Eulalio; Isabelle Behm-Ansmant; Daniel Schweizer; Elisa Izaurralde
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

6.  HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.

Authors:  Prabhjeet K Phalora; Nathan M Sherer; Steven M Wolinsky; Chad M Swanson; Michael H Malim
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

7.  Mutational analysis of the feline immunodeficiency virus matrix protein.

Authors:  M L Manrique; C C Celma; S A González; J L Affranchino
Journal:  Virus Res       Date:  2001-07       Impact factor: 3.303

8.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

9.  Conservation of a stepwise, energy-sensitive pathway involving HP68 for assembly of primate lentivirus capsids in cells.

Authors:  Julia E Dooher; Jaisri R Lingappa
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  The SWISS-MODEL Repository and associated resources.

Authors:  Florian Kiefer; Konstantin Arnold; Michael Künzli; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2008-10-18       Impact factor: 16.971

View more
  7 in total

1.  Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.

Authors:  Brook C Barajas; Motoko Tanaka; Bridget A Robinson; Daryl J Phuong; Kasana Chutiraka; Jonathan C Reed; Jaisri R Lingappa
Journal:  PLoS Pathog       Date:  2018-04-17       Impact factor: 6.823

Review 2.  Strategies for Success. Viral Infections and Membraneless Organelles.

Authors:  Aracelly Gaete-Argel; Chantal L Márquez; Gonzalo P Barriga; Ricardo Soto-Rifo; Fernando Valiente-Echeverría
Journal:  Front Cell Infect Microbiol       Date:  2019-10-11       Impact factor: 5.293

3.  The Conserved Tyr176/Leu177 Motif in the α-Helix 9 of the Feline Immunodeficiency Virus Capsid Protein Is Critical for Gag Particle Assembly.

Authors:  César A Ovejero; Silvia A González; José L Affranchino
Journal:  Viruses       Date:  2019-09-04       Impact factor: 5.048

Review 4.  HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking.

Authors:  Lucas A Tavares; Yunan C Januário; Luis L P daSilva
Journal:  Front Cell Dev Biol       Date:  2021-07-08

Review 5.  Properties and Functions of Feline Immunodeficiency Virus Gag Domains in Virion Assembly and Budding.

Authors:  Silvia A González; José L Affranchino
Journal:  Viruses       Date:  2018-05-16       Impact factor: 5.048

6.  Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.

Authors:  Jonathan C Reed; Dennis Solas; Anatoliy Kitaygorodskyy; Beverly Freeman; Dylan T B Ressler; Daryl J Phuong; J Victor Swain; Kent Matlack; Clarence R Hurt; Vishwanath R Lingappa; Jaisri R Lingappa
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 7.  Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs-First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor.

Authors:  Jaisri R Lingappa; Vishwanath R Lingappa; Jonathan C Reed
Journal:  Viruses       Date:  2021-03-10       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.